# Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC

> **NCT02175381** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hellenic Oncology Research Group** · enrollment: 69 (actual)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT02175381
- **Lead sponsor:** Hellenic Oncology Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2015-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02175381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02175381, "Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02175381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*